W Ma, CL Del Rio, L Qi, M Prodanovic… - Proceedings of the …, 2024 - National Acad Sciences
Mavacamten is a FDA-approved small-molecule therapeutic designed to regulate cardiac
function at the sarcomere level by selectively but reversibly inhibiting the enzymatic activity …